Skip Navigation



Carcinogenesis Advance Access published online on September 14, 2006
Carcinogenesis, doi:10.1093/carcin/bgl158
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
28/3/553    most recent
bgl158v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Rebuzzini, P.
Right arrow Articles by Mondello, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rebuzzini, P.
Right arrow Articles by Mondello, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org
Received May 3, 2006
Revised August 18, 2006
Accepted August 21, 2006

CANCER BIOLOGY

Inhibition of gene amplification in telomerase deficient immortalized mouse embryonic fibroblasts

Paola Rebuzzini 1, Paola Martinelli 1, Maria Blasco 2, Elena Giulotto 3, and Chiara Mondello 1 *

1 Istituto di Genetica Molecolare, CNR, Via Abbiategrasso 207, 27100 Pavia, Italy
2 Spanish National Cancer Center, Melchor Fernández Almagro 3, 28029 Madrid, Spain
3 Dipartimento di Genetica e Microbiologia "Adriano Buzzati Traverso", University of Pavia, Via Ferrata 1, 27100 Pavia, Italy

* To whom correspondence should be addressed.
Chiara Mondello, E-mail: mondello{at}igm.cnr.it


  Abstract

Mutations in genes important for the preservation of genome stability can increase the frequency of gene amplification, a process relevant to tumor development. To investigate whether telomerase, the enzyme deputed to telomere maintenance, plays also a role in gene amplification, we studied the amplification of the carbamyl-P-synthetase, aspartate transcarbamilase, dihydro-orotase (CAD) gene in immortalized embryonic fibroblasts derived from telomerase knockout mice (mTERC-/-) of the first and of the sixth generation. As expected, in 9 out of 10 N-(phosphonacetyl)-L-aspartate (PALA) resistant clones derived from wild type cells, CAD was amplified; in contrast, in none of the 30 PALA resistant clones isolated from the three mTERC-/- cell lines we could detect CAD amplification, indicating that, in the absence of telomerase activity, gene amplification is inhibited. The causal relationship between mTERC deficiency and lack of gene amplification was demonstrated by the restoration of CAD gene amplification in two of the three deficient cell lines transfected with mTERC. The lack of amplification in mTERC deficient cells could be related to a defect in the stabilization of the ends of the amplified chromosomes in the absence of telomerase, to a more general effect of telomerase in the regulation of gene expression, including genes involved in amplification, or to a possible interaction of the telomerase RNA with proteins involved in gene amplification.

Keywords: BFB cycles; gene amplification; telomeres; telomerase; PALA.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.